Diets · Metabolic & Cardiometabolic
replacing saturated fat with linoleic-acid vegetable oil increases mortality / coronary heart disease
In plain terms: If you swap butter and animal fat for vegetable oils high in linoleic acid, do you die sooner?
The recovered old-trial data are split: vegetable-oil swaps cut cholesterol but gave no survival benefit and in the Sydney trial significantly raised deaths, yet larger pooled RCTs show the swap actually reduces heart-disease events, so a blanket "raises mortality" claim is not supported.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
<!-- vault-context --> Norwitz affirms this claim. Consensus below reflects independent literature only.
The evidence (13)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Del Carmen Fernández-Fígares Jiménez M 2025 · Curr Nutr Rep | observational | contradicts | low | Review reports that substituting butter with soft margarine (a PUFA-rich, partially vegetable-oil-based product) reduces total cholesterol and LDL-C and is associated with lower risk of cardiovascular events and mortality; soymilk replacing dairy milk also red |
| Skeaff 2009 · Ann Nutr Metab | meta-analysis | contradicts | moderate | Summary of cohort and RCT evidence: replacing saturated with polyunsaturated fat lowers coronary heart disease risk. |
| Schwingshackl 2014 · BMJ Open | meta-analysis | contradicts | moderate | Meta-analysis of secondary-prevention trials found modified/PUFA-substituted fat diets did not increase and tended to reduce cardiovascular events. |
| Hooper L, et al. 2020 · Cochrane Database Syst Rev | meta-analysis | contradicts | high | Cochrane: reducing/replacing satfat cut CV events 17% with no excess mortality; high attrition & trans-fat confounding flagged as limits of the old recovered trials. |
| Fridén M 2025 · Nat Commun | RCT | contradicts | moderate | In a 150-person RCT (NAFLDiet), a low-carbohydrate high-PUFA diet (replacing carbohydrate, not directly SFA, with PUFA) reduced liver fat by 1.46% and LDL-cholesterol versus usual care over 12 months, with no serious adverse events attributable to diet; no mor |
| Hooper 2020 · Cochrane Database Syst Rev | meta-analysis | contradicts | high | Cochrane review: reducing saturated fat cut cardiovascular events, with no increase in mortality; supports the swap being beneficial/neutral. |
| Imamura 2016 · PLoS Med | meta-analysis | contradicts | moderate | RCT feeding-trial meta-analysis: replacing saturated fat/carbohydrate with PUFA improves glucose-insulin homeostasis, undercutting harm narrative. |
| Mozaffarian 2010 · PLoS Med | meta-analysis | contradicts | high | Pooled PUFA-for-SFA RCTs: the swap REDUCED CHD events ~19% (RR0.81), the opposite of an across-the-board mortality increase. |
| Ramsden 2013 · BMJ | RCT | supports | moderate | Recovered Sydney Diet Heart RCT (n=458 post-MI men): safflower-oil-for-satfat swap raised all-cause (HR1.62), CV (1.70) and CHD (1.74) death. |
| Farvid 2014 · Circulation | meta-analysis | contradicts | high | Dose-response meta-analysis of cohorts: higher dietary linoleic acid associated with lower, not higher, coronary heart disease risk. |
| Miller M 2026 · JACC Adv | observational | contradicts | moderate | This clinician's guide to 2026 CV nutrition controversies places seed oils in the 'evidence of benefit' category (alongside seafood), based on improved CVD outcomes, in contrast to beef tallow and ultraprocessed foods which are placed in the 'evidence of harm' |
| Hooper 2012 · Cochrane Database Syst Rev | meta-analysis | contradicts | high | Cochrane review of reduced/modified fat diets shows reduced cardiovascular events without raising total mortality. |
| Ramsden CE, et al. 2016 · BMJ | RCT | mixed | moderate | Recovered Minnesota Coronary Experiment (n=9,423): linoleic-oil swap lowered cholesterol but gave NO mortality benefit; randomized comparison null, no significant overall harm. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.